Who are in the management team of ImmunoGen, Inc.?

Jun 22 2025 10:00 PM IST
share
Share Via
As of March 2022, the management team of ImmunoGen, Inc. includes Mr. Stephen McCluski (Independent Chairman), Mr. Mark Enyedy (President and CEO), and several independent directors: Mr. Stuart Arbuckle, Dr. Mark Goldberg, Mr. Dean Mitchell, Ms. Kristine Peterson, and Mr. Richard Wallace. They oversee the company's strategic direction and operations.
As of March 2022, the management team of ImmunoGen, Inc. includes the following individuals:

- Mr. Stephen McCluski, Independent Chairman of the Board
- Mr. Mark Enyedy, President, Chief Executive Officer, Director
- Mr. Stuart Arbuckle, Independent Director
- Dr. Mark Goldberg, Independent Director
- Mr. Dean Mitchell, Independent Director
- Ms. Kristine Peterson, Independent Director
- Mr. Richard Wallace, Independent Director

This team is responsible for guiding the company's strategic direction and overseeing its operations.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
How big is ImmunoGen, Inc.?
Jun 22 2025 05:29 PM IST
share
Share Via